Ticker: CBPO, Company: China Biologic Products Holdings, Inc., Type: S-8, Date: 2020-05-08
Original SEC Filing: Click here

---

Webplus: CBPO/20200508/S-8_1/1/000.htm SEC Original: tm2018943d1_s8.htm

---

---

Webplus: CBPO/20200508/S-8_1/2_EX-5.1/000.htm SEC Original: tm2018943d1_ex5-1.htm
Ref: KKZ/728498-000001/14732213v4 China Biologic Products Holdings, Inc. Room 1801, 18/F., Jialong International Tower No. 19 Chaoyang Park Road Chaoyang District Beijing 100125 China 8 May 2020 Dear Sir and/or Madam China Biologic Products Holdings, Inc. (the “Company”) Commission Registration Statement Securities Act Shares Plan Memorandum and Articles Minutes For the purposes of giving this opinion, we have examined copies of

---

---

Webplus: CBPO/20200508/S-8_1/3_EX-23.2/000.htm SEC Original: tm2018943d1_ex23-2.htm
Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the use of our reports dated March 12, 2020, with respect to the consolidated balance sheets of China Biologic Products Holdings, Inc. and subsidiaries as of December 31, 2019 and 2018, and the related consolidated statements of comprehensive income, changes in equity and cash flows for

---

Company Info:

Ticker: CBPO, Company: China Biologic Products Holdings, Inc., Type: S-8, Date: 2020-05-08CIK: 0001369868, Location: F4, SIC: 2836, SIC Desc: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Business Phone & Address:
18TH FL, JIALONG INTERNATIONALBUILDING, 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT
BEIJING 100125